7RD9
Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.159
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-04-25 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 1 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 93.920, 62.004, 75.137 |
Unit cell angles | 90.00, 105.87, 90.00 |
Refinement procedure
Resolution | 34.320 - 1.910 |
R-factor | 0.1887 |
Rwork | 0.186 |
R-free | 0.23330 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6b5l |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX (1.19.1_4122) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 1.940 |
High resolution limit [Å] | 1.910 | 5.180 | 1.910 |
Rmerge | 0.177 | 0.069 | 0.555 |
Rmeas | 0.201 | 0.084 | 0.631 |
Rpim | 0.092 | 0.046 | 0.294 |
Total number of observations | 142340 | ||
Number of reflections | 30463 | 1120 | 1501 |
<I/σ(I)> | 6.9 | ||
Completeness [%] | 94.1 | 66.9 | 92.1 |
Redundancy | 4.7 | 2.8 | 4.4 |
CC(1/2) | 0.990 | 0.783 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1 M sodium acetate trihydrate, pH 4.0, 10% w/v PEG4000 |